BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31750934)

  • 1. Magnitude of reduction in risk of second contralateral breast cancer with bilateral mastectomy in patients with breast cancer: Data from California, 1998 through 2015.
    Kurian AW; Canchola AJ; Ma CS; Clarke CA; Gomez SL
    Cancer; 2020 Mar; 126(5):958-970. PubMed ID: 31750934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second invasive breast cancers in patients treated with breast-conserving therapy.
    Wang J; Tang H; Yin K; Li X; Xie X; Hughes KS
    Eur J Surg Oncol; 2021 Oct; 47(10):2492-2498. PubMed ID: 34134902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women.
    Yoon TI; Kwak BS; Yi OV; Kim S; Um E; Yun KW; Shin HN; Lee S; Sohn G; Chung IY; Kim J; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
    Breast Cancer Res Treat; 2019 Feb; 173(3):657-665. PubMed ID: 30377870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival analysis of contralateral prophylactic mastectomy: a question of selection bias.
    Kruper L; Kauffmann RM; Smith DD; Nelson RA
    Ann Surg Oncol; 2014 Oct; 21(11):3448-56. PubMed ID: 25047478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma.
    Zablotska LB; Neugut AI
    Cancer; 2003 Mar; 97(6):1404-11. PubMed ID: 12627503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race, ethnicity and risk of second primary contralateral breast cancer in the United States.
    Watt GP; John EM; Bandera EV; Malone KE; Lynch CF; Palmer JR; Knight JA; Troester MA; Bernstein JL
    Int J Cancer; 2021 Jun; 148(11):2748-2758. PubMed ID: 33544892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast-conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population-based study.
    Yu P; Liu P; Zou Y; Xie X; Tang H; Li N; Xie X; Ye F
    Cancer Med; 2020 Aug; 9(15):5381-5391. PubMed ID: 32515157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone receptor status of contralateral breast cancers: analysis of data from the US SEER population-based registries.
    Mezencev R; Švajdler M
    Breast Cancer; 2017 May; 24(3):400-410. PubMed ID: 27502779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011.
    Kurian AW; Lichtensztajn DY; Keegan TH; Nelson DO; Clarke CA; Gomez SL
    JAMA; 2014 Sep; 312(9):902-14. PubMed ID: 25182099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher Stage of Disease Is Associated With Bilateral Mastectomy Among Patients With Breast Cancer: A Population-Based Survey.
    Freedman RA; Kouri EM; West DW; Rosenberg S; Partridge AH; Lii J; Keating NL
    Clin Breast Cancer; 2016 Apr; 16(2):105-12. PubMed ID: 26410475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.
    Galper S; Gelman R; Recht A; Silver B; Kohli A; Wong JS; Van Buren T; Baldini EH; Harris JR
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):406-14. PubMed ID: 11872286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
    Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
    Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rising Bilateral Mastectomy Rates Among Neoadjuvant Chemotherapy Recipients in California From 1998 to 2012.
    Wapnir IL; Kurian AW; Lichtensztajn DY; Clarke CA; Gomez SL
    Ann Surg; 2017 Aug; 266(2):353-360. PubMed ID: 27611617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival outcomes after breast-conserving therapy compared with mastectomy for patients with early-stage metaplastic breast cancer: a population-based study of 2412 patients.
    Zhang J; Yang C; Lei C; Zhang Y; Ji F; Gao H; Yang M; Zhang L; Li J; Zhu T; Li W; Zhuang X; Wang K
    Breast; 2021 Aug; 58():10-17. PubMed ID: 33878598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy.
    Agarwal S; Pappas L; Matsen CB; Agarwal JP
    Cancer Med; 2020 Nov; 9(21):8043-8052. PubMed ID: 32918537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast conservation versus mastectomy for patients with T3 primary tumors (>5 cm): A review of 5685 medicare patients.
    Bleicher RJ; Ruth K; Sigurdson ER; Daly JM; Boraas M; Anderson PR; Egleston BL
    Cancer; 2016 Jan; 122(1):42-9. PubMed ID: 26479066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast surgery for young women with early-stage breast cancer: Mastectomy or breast-conserving therapy?
    Sun ZH; Chen C; Kuang XW; Song JL; Sun SR; Wang WX
    Medicine (Baltimore); 2021 May; 100(18):e25880. PubMed ID: 33951002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
    Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
    Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of adjuvant radiotherapy after breast-conserving therapy among elderly women with T1-T2N0 estrogen receptor-negative breast cancer.
    Eaton BR; Jiang R; Torres MA; Kahn ST; Godette K; Lash TL; Ward KC
    Cancer; 2016 Oct; 122(19):3059-68. PubMed ID: 27328114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second primary in the contralateral breast after treatment of breast cancer.
    Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor RK
    Radiother Oncol; 2008 Feb; 86(2):171-6. PubMed ID: 17961777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.